Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 184

1.

How low can you get?

Brincat M, Baron YM, Galea R.

Ann N Y Acad Sci. 2003 Nov;997:158-62. Review.

PMID:
14644822
2.
3.

Endothelial function across an oral contraceptive cycle in women using levonorgestrel and ethinyl estradiol.

Torgrimson BN, Meendering JR, Kaplan PF, Minson CT.

Am J Physiol Heart Circ Physiol. 2007 Jun;292(6):H2874-80. Epub 2007 Feb 2.

4.

[Clinical study of the low dose oral contraceptive novynette].

Uchikova E, Milchev N.

Akush Ginekol (Sofiia). 2003;42(4):15-6. Bulgarian.

PMID:
14577362
5.

Evaluation of a continuous regimen of levonorgestrel/ethinyl estradiol: phase 3 study results.

Archer DF, Jensen JT, Johnson JV, Borisute H, Grubb GS, Constantine GD.

Contraception. 2006 Dec;74(6):439-45. Epub 2006 Sep 18.

PMID:
17157099
6.
7.
8.

Biphasic versus triphasic oral contraceptives for contraception.

van Vliet HA, Grimes DA, Helmerhorst FM, Schulz KF.

Contraception. 2002 May;65(5):321-4. Review.

PMID:
12057781
9.

Bleeding patterns after immediate initiation of an oral compared with a vaginal hormonal contraceptive.

Westhoff C, Osborne LM, Schafer JE, Morroni C.

Obstet Gynecol. 2005 Jul;106(1):89-96.

PMID:
15994622
10.

Combined hormonal contraception.

Calderoni ME, Coupey SM.

Adolesc Med Clin. 2005 Oct;16(3):517-37.

PMID:
16183537
11.

Ethinyl estradiol and 17β-estradiol in combined oral contraceptives: pharmacokinetics, pharmacodynamics and risk assessment.

Stanczyk FZ, Archer DF, Bhavnani BR.

Contraception. 2013 Jun;87(6):706-27. doi: 10.1016/j.contraception.2012.12.011. Epub 2013 Jan 8. Review.

PMID:
23375353
12.

Efficacy, acceptability and tolerability of the combined contraceptive ring, NuvaRing, compared with an oral contraceptive containing 30 microg of ethinyl estradiol and 3 mg of drospirenone.

Ahrendt HJ, Nisand I, Bastianelli C, Gómez MA, Gemzell-Danielsson K, Urdl W, Karskov B, Oeyen L, Bitzer J, Page G, Milsom I.

Contraception. 2006 Dec;74(6):451-7. Epub 2006 Sep 27.

PMID:
17157101
13.

[Clinical study of two monophase oral contraceptives with desogestrel].

Uchikova E, Milchev N, Markova D, Batashki I, Gŭrova A.

Akush Ginekol (Sofiia). 2007;46(2):18-21. Bulgarian.

PMID:
17469446
14.

Effect of a combination of ethinylestradiol 30 microg and drospirenone 3 mg on tolerance, cycle control, general well-being and fluid-related symptoms in women with premenstrual disorders requesting contraception.

Borges LE, Andrade RP, Aldrighi JM, Guazelli C, Yazlle ME, Isaia CF, Petracco A, Peixoto FC, Camargos AF.

Contraception. 2006 Dec;74(6):446-50. Epub 2006 Oct 19.

PMID:
17157100
16.

Low-dose oral contraceptives: health consequences of discontinuation.

Ansbacher R.

Contraception. 2000 Dec;62(6):285-8. Review.

PMID:
11239614
17.

Low-dose ethinylestradiol/levonorgestrel.

Dando TM, Curran MP.

Drugs. 2005;65(16):2299-306; discusion 2307-8. Review.

PMID:
16266199
18.

Oral contraceptive tolerance: does the type of pill matter?

Moreau C, Trussell J, Gilbert F, Bajos N, Bouyer J.

Obstet Gynecol. 2007 Jun;109(6):1277-85.

PMID:
17540798
19.

Manipulation of the pill-free interval in oral contraceptive pill users: the effect on follicular suppression.

Schlaff WD, Lynch AM, Hughes HD, Cedars MI, Smith DL.

Am J Obstet Gynecol. 2004 Apr;190(4):943-51.

PMID:
15118618
20.
Items per page

Supplemental Content

Write to the Help Desk